BioWorld

Jan. 27, 2004

View Archived Issues

Northfield To Support PolyHeme Pivotal Trial With $15M Financing

Blood substitute developer Northfield Laboratories Inc. topped off the tank with $15 million in financing to fund a pivotal trial of its lead product, PolyHeme. (BioWorld Today) Read More

Cypress Licenses Collegium's Patent Portfolio For Milnacipran

Read More

No Cure In Sight, No Cause In View, Gastroenterologists Soldier On To Try Assuagement Of Crohn's Illness

Read More

CryoLife Privately Raises $20M, Calls Near Term 'Very Promising'

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More